Clinical trial
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
NCT00096798 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00096798 |
|---|---|
| Title | Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression |
| Official title | A Double-Blind, Placebo-Controlled Study of Ethyl Eicosapentanoic Acid (Ethyl-EPA) in Major Depressive Disorder |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Depression |
| Intervention type | Drug |
| Interventions | Ethyl-eicosapentanoic acid (ethyl-EPA) |
| Enrollment | 80 |
| Start date | Sep 1, 2001 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Nov 16, 2004 |
| Last update posted | Jan 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: